Sequential activation of activator protein-1-related transcription factors and JNK protein kinases may contribute to apoptotic death induced by transient hypoxia in developing brain neurons.
Previous studies have demonstrated that transient hypoxia (6 h) induces apoptotic death in cultured neurons isolated from the fetal rat forebrain. Since activation of c-Jun N-terminal kinases (JNKs) and subsequent phosphorylation of c-Jun are suspected to be involved in the apoptotic pathway in several cell types, the time course of activator protein-1 (AP-1) DNA-binding, in line with induction of the AP-1 components and JNK activation, was examined during hypoxia/reoxygenation in the same model. Gel shift analysis depicted the presence of functional AP-1 transcription factors in both control and hypoxic neurons. One hour after the onset of hypoxia, all AP-1 components were markedly overexpressed. They include c-Jun, Jun B, Jun D, c-Fos and Fos-related antigens. Whereas, only c-Jun remained elevated for up to 96 h post-reoxygenation, time at which neurons were injured, other gene products showed patterned induction/repression as hypoxia progressed and then during the post-reoxygenation period, with Fos-related antigens being finally induced at 96 h. Only JNK1 was constitutively detected in cultured neurons, and its expression was inhibited during hypoxia. Nonetheless, both JNK1 and JNK3 were markedly, but transiently, induced at 48 h post-reoxygenation, when apoptosis-related morphological features became apparent. These data support the hypothesis that transient hypoxia, independently of ischemia, may trigger apoptosis through JNK signaling pathway in developing brain neurons.
Chihab
R
R
JE 2164 and INSERM U.272, Université Henri Poincaré-Nancy 1, Nancy, France.
Ferry
C
C
Koziel
V
V
Monin
P
P
Daval
J L
JL
D000818:Animals; D000906:Antibodies; D017209:Apoptosis / Q000502:physiology*; D001921:Brain / Q000098:blood supply / Q000196:embryology / Q000201:enzymology; D001923:Brain Chemistry / Q000502:physiology; D002470:Cell Survival / Q000502:physiology; D002478:Cells, Cultured; D005260:Female; D002534:Hypoxia, Brain / Q000503:physiopathology*; D002546:Ischemic Attack, Transient / Q000503:physiopathology; D048031:JNK Mitogen-Activated Protein Kinases; D048670:MAP Kinase Kinase 4; D008297:Male; D020929:Mitogen-Activated Protein Kinase Kinases; D009474:Neurons / Q000737:chemistry / Q000166:cytology* / Q000201:enzymology; D011247:Pregnancy; D011494:Protein Kinases / Q000032:analysis / Q000276:immunology / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000503:physiopathology; D018808:Transcription Factor AP-1 / Q000032:analysis / Q000276:immunology / Q000378:metabolism*
D000906:Antibodies; D018808:Transcription Factor AP-1; D011494:Protein Kinases; D048031:JNK Mitogen-Activated Protein Kinases; D048670:MAP Kinase Kinase 4; D020929:Mitogen-Activated Protein Kinase Kinases